Researchers

no image

ITO Masaoki
Lecturer in Medical School
Faculty Department of Medicine
Researchmap https://researchmap.jp/masaokiito

Research Activities

Published Papers

  1. Modified dual-portal robotic-assisted thoracic surgery using a Japanese-manufactured robotic platform
    Hideki Ujiie; Masaoki Ito; Hana Oiki; Shota Fukuda; Mai Nishina; Shuta Ohara; Masaya Nishino; Akira Hamada; Masato Chiba; Toshiki Takemoto; Yasuhiro Tsutani
    JTCVS Techniques  Jun. 2026  , Refereed
  2. The Hisashi technique: Making a “pent roof” for safe and curative lung segmentectomy
    Hideki Ujiie; Masaoki Ito; Hana Oiki; Shota Fukuda; Mai Nishina; Shuta Ohara; Masaya Nishino; Akira Hamada; Masato Chiba; Toshiki Takemoto; Yasuhiro Tsutani
    JTCVS Techniques  Jun. 2026  , Refereed
  3. Frequent RBM10 Comutation and a Mutually Exclusive Relationship With Other TP53 Pathway Aberrations in Early-Stage Non-Small-Cell Lung Cancer with EGFR Mutation.
    Kenichi Suda; Kazuko Sakai; Masaoki Ito; Hana Oiki; Shota Fukuda; Shuta Ohara; Akira Hamada; Masato Chiba; Masaki Shimoji; Kazuto Nishio; Yasuhiro Tsutani
    Clinical lung cancer  10, Mar. 2026 

MORE

MISC

  1. 当院における切除可能非小細胞肺癌に対する術前免疫療法の病理学的効果および安全性の検討 , 緒方 琴美; 福田 祥大; 濱田 顕; 老木 華; 仁科 麻衣; 西野 将矢; 千葉 眞人; 伊藤 正興; 武本 智樹; 氏家 秀樹; 津谷 康大 , 肺癌 , 66 , 3 , 217 , 217 , Jun. 2026
  2. 当院で免疫療法後にサルベージ術を行なった5例の検討 , 仁科 麻衣; 老木 華; 福田 祥大; 小原 秀太; 西野 将矢; 濱田 顕; 千葉 眞人; 伊藤 正興; 武本 智樹; 氏家 秀樹; 津谷 康大 , 肺癌 , 66 , 3 , 218 , 218 , Jun. 2026
  3. 隣接臓器合併切除を伴う局所進行肺癌手術における手技の工夫～適応の限界とアプローチ～ ロボット時代の局所進行肺癌手術(Surgical Strategies for Locally Advanced Lung Cancer Requiring Combined Resection of Adjacent Organs: Limits of Indication and Operative Approaches Surgery for Locally Advanced Lung Cancer in the Robotic Era) , 千葉 眞人; 老木 華; 福田 祥大; 仁科 麻衣; 伊藤 正興; 小原 秀太; 西野 将矢; 濱田 顕; 武本 智樹; 氏家 秀樹; 津谷 康大 , 日本外科学会定期学術集会抄録集 , 126回 , WS , 8 , Apr. 2026

MORE

Research Grants & Projects

  1. 日本学術振興会, 科学研究費助成事業, 遺伝子変異数及び癌関連遺伝子発現量による原発性肺癌の層別化方法の開発 , 近畿大学
  2. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Targeted therapy for the patient with KRAS mutant lung cancer
  3. International Association for the Study of Lung Cancer, IASLC FELLOWSHIP GRANT 2017, the potential oncogenic role of the p21-activated kinase 1 (PAK1) as a novel approach for personalized therapy in non-small cell lung cancer (NSCLC) , Institut d´Investigació en Ciències de la Salut Germans Trias i Pujol Campus Can Ruti, Badalona, Barcelona, Spain

MORE